Do Artemisia annua L. compounds have SARS-CoV-2 antiviral potential?
4.6 (706) · € 38.50 · En Stock
.jpg)
Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective
Artemisia annua L. extracts prevent in vitro replication of SARS-CoV-2
SARS-CoV-2 omicron variants are susceptible in vitro to Artemisia annua hot water extracts - ScienceDirect
Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect
Saponin and Immune Stimulant Based Gargles and Nasal Rinses: A Potential Virucidal for Preventive Management of SARS-CoV-2 Infection?
Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect
Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials in: The American Journal of Tropical Medicine and Hygiene Volume 103 Issue 3 (2020)
Therapeutic opportunities of edible antiviral plants for COVID-19
Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19), BMC Complementary Medicine and Therapies
Life, Free Full-Text
In vitro efficacy of artemisinin-based treatments against SARS-CoV-2
Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine - ScienceDirect
Life, Free Full-Text
Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials in: The American Journal of Tropical Medicine and Hygiene Volume 103 Issue 3 (2020)
